/

Sociétés

Cu

Non vérifié

Cure Rare Disease

Ce que nous écrivons

BiotechnologieIndustrie pharmaceutiqueSantéScienceVolontariat/Solidarité/Bénévolat

9 communiqués de presse

Voir tous les communiqués de presse

24/09/2025

Volontariat/Solidarité/Bénévolat

Industrie

Santé

Hygiène alimentaire

Biotechnologie

Médecine - Divers

Industrie pharmaceutique

Cure Rare Disease Secures FDA Orphan Drug Designation for Investigational Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type R9 (LGMD2i/R9)

Source

Cure Rare Disease

Émetteur

1.00

0

24/06/2025

Science

Hygiène alimentaire

Biotechnologie

Santé

Industrie pharmaceutique

Santé Publique

Volontariat/Solidarité/Bénévolat

Industrie

Cure Rare Disease Receives FDA Feedback on Limb-Girdle 2i/R9 Gene Therapy Program Following Successful Pre-IND Meeting

Source

Cure Rare Disease

Émetteur

1.00

0

23/06/2025

Science

Hygiène alimentaire

Biotechnologie

Santé

Industrie pharmaceutique

Santé Publique

Volontariat/Solidarité/Bénévolat

Industrie

Cure Rare Disease Receives FDA Feedback on Limb-Girdle 2i/R9 Gene Therapy Program Following Successful Pre-IND Meeting

Source

Cure Rare Disease

Émetteur

1.00

0

09/06/2025

Science

Biotechnologie

Industrie pharmaceutique

Santé Publique

Santé

Volontariat/Solidarité/Bénévolat

Marché du travail

Cure Rare Disease Welcomes New Scientific and Strategic Leaders to Advance Therapies for Ultra-Rare Conditions

Source

Cure Rare Disease

Émetteur

1.00

0

14/05/2025

Volontariat/Solidarité/Bénévolat

Industrie

Science

Biotechnologie

Industrie pharmaceutique

Santé

Hygiène alimentaire

Médecine - Divers

Cure Rare Disease Receives Orphan Drug Designation from FDA for Investigational Therapy Targeting Spinocerebellar Ataxia Type 3 (SCA3)

Source

Cure Rare Disease

Émetteur

1.00

0

03/04/2025

Multimédia

Volontariat/Solidarité/Bénévolat

Événements

Biotechnologie

Sports Divers

Santé

Famille

Vitrines/Shopping

Associations/Professionnels

Science

Enfance

We Row For William: 157 Miles, One Nonstop Journey of Hope

Source

Cure Rare Disease

Émetteur

1.00

0

06/02/2025

Biotechnologie

Santé

Science

Volontariat/Solidarité/Bénévolat

Cure Rare Disease Awarded $5.69 Million CIRM Grant to Advance Gene Therapy for Spinocerebellar Ataxia Type 3

Source

Cure Rare Disease

Émetteur

1.00

0

18/12/2024

Cure Rare Disease Appoints Brittany Stineman as Chief Advancement Officer

Source

Cure Rare Disease

Émetteur

1.00

0

18/12/2024

Cure Rare Disease Appoints Brittany Stineman as Chief Advancement Officer

Source

Cure Rare Disease

Émetteur

1.00

0

Followers

0

Compatibilité

0